An appraisal of endoscopic retrograde cholangiopancreatography (ERCP) for pancreaticobiliary disease in children: our institutional experience in 231 cases
Abstract:Endoscopic retrograde cholangiopancreatography was used most commonly for children with pancreatitis and gallstone disease. It was used frequently for infants with a low complication rate. The majority of patients required therapeutic intervention, suggesting an important role for ERCP in the management of pancreaticobiliary disease in infants and children.
“…In older children, the success rate for cannulation of the desired duct is 97-98% comparable to that achieved in adults [1][2][3][4][5][11][12][13][14][15][16][17][18]. Our ERCP success in 220 children older than 1 year was 98%.…”
Section: Pancreatic Indicationsmentioning
confidence: 52%
“…In neonates and young infants with neonatal cholestasis, there were no major complications in the series reported in the literature [1][2][3][4][5]. In our unpublished experience with 184 neonates and young infants, minor complications without clinical significance occurred in 24 patients (13%).…”
Section: Complicationsmentioning
confidence: 83%
“…The overall incidence is approximately 5% [1][2][3][4][5]. In our unpublished experience with 220 ERCPs in children older than 1 year, ERCP was performed for diagnostic purposes in 108 cases with two (1.8%) complications.…”
Section: Complicationsmentioning
confidence: 99%
“…ERCP has been found to be useful in the treatment of chronic pancreatitis in 14-69% of children with recurrent pancreatitis [1][2][3][4][5]55]. In children with chronic pancreatitis, debilitating pain and recurrent attacks may be caused by strictures of the main duct, pancreatic stones, or pseudocysts that impair the normal outflow of pancreatic secretions.…”
Section: Chronic Pancreatitismentioning
confidence: 99%
“…It is the most sensitive and specific technique in the evaluation and treatment of children with suspected disorders of the pancreas and the biliary tract. It is now routinely used for therapeutic purposes [1][2][3][4][5] since magnetic resonance cholangiopancreatography (MRCP) is nowadays the Key poInts…”
“…In older children, the success rate for cannulation of the desired duct is 97-98% comparable to that achieved in adults [1][2][3][4][5][11][12][13][14][15][16][17][18]. Our ERCP success in 220 children older than 1 year was 98%.…”
Section: Pancreatic Indicationsmentioning
confidence: 52%
“…In neonates and young infants with neonatal cholestasis, there were no major complications in the series reported in the literature [1][2][3][4][5]. In our unpublished experience with 184 neonates and young infants, minor complications without clinical significance occurred in 24 patients (13%).…”
Section: Complicationsmentioning
confidence: 83%
“…The overall incidence is approximately 5% [1][2][3][4][5]. In our unpublished experience with 220 ERCPs in children older than 1 year, ERCP was performed for diagnostic purposes in 108 cases with two (1.8%) complications.…”
Section: Complicationsmentioning
confidence: 99%
“…ERCP has been found to be useful in the treatment of chronic pancreatitis in 14-69% of children with recurrent pancreatitis [1][2][3][4][5]55]. In children with chronic pancreatitis, debilitating pain and recurrent attacks may be caused by strictures of the main duct, pancreatic stones, or pseudocysts that impair the normal outflow of pancreatic secretions.…”
Section: Chronic Pancreatitismentioning
confidence: 99%
“…It is the most sensitive and specific technique in the evaluation and treatment of children with suspected disorders of the pancreas and the biliary tract. It is now routinely used for therapeutic purposes [1][2][3][4][5] since magnetic resonance cholangiopancreatography (MRCP) is nowadays the Key poInts…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.